Skip to main content
. 2019 Apr 16;37(16):1403–1411. doi: 10.1200/JCO.19.00394

FIG 3.

FIG 3.

MYD88 mutation status is an independent risk factor for progression to symptomatic Waldenström macroglobulinemia. The Kaplan-Meier method was used to compare progression-free survival between patients with MYD88 L265P and wild-type (WT) disease.